Solventum Corporation shares fall 1.25% intraday after completing the sale of its Purification & Filtration business.

Solventum Corporation declined 1.25% in intraday trading, following the completion of the sale of its Purification & Filtration business to Thermo Fisher Scientific Inc. for $4.0 billion in cash. The proceeds from the sale will be used to pay down outstanding debt, strengthening the company's balance sheet and providing greater flexibility for future investments.